Results 111 to 120 of about 1,619,240 (186)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study. [PDF]

Diabetes Metab J, 2021
Moon JS, Suh S, Kim SS, Jin HY, Kim JM, Jang MH, Lee KA, Lee JH, Chung SM, Lyu YS, Kim JH, Kim SY, Jang JE, Kim TN, Kim SW, Jeon E, Cho NH, Kim MK, Kim HS, Nam-Goong IS, Kim ES, Chung JO, Cho DH, Lee CW, Kim YI, Chung DJ, Won KC, Kim IJ, Park TS, Kim DK, Shon H.   +30 more
europepmc   +1 more source

Hypoglycemic agents and bone health; an umbrella systematic review of the clinical trials' meta-analysis studies. [PDF]

Diabetol Metab Syndr
Khashayar P, Rad FF, Tabatabaei-Malazy O, Golabchi SM, Khashayar P, Mohammadi M, Ebrahimpour S, Larijani B.   +7 more
europepmc   +1 more source

Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus. [PDF]

Diabetes Metab J
Kim HS.
europepmc   +1 more source

Hypoglycemic Agents Increase Regulatory Factor X1 to Inhibit Cancer Cell Behaviour in Human Glioblastoma Cells. [PDF]

J Cell Mol Med
Shan W, Zuo K, Zuo Z.
europepmc   +1 more source

Identification of Plant Phenolics from <i>Paulownia tomentosa</i> and <i>Morus alba</i> as Novel PPARγ Partial Agonists and Hypoglycemic Agents. [PDF]

J Agric Food Chem
Treml J, Václavík J, Molčanová L, Čulenová M, Hummelbrunner S, Neuhauser C, Dirsch VM, Weghuber J, Šmejkal K.   +8 more
europepmc   +1 more source

Effect of hypoglycemic agents with weight loss effect plus a high protein diet and moderate exercise on diabetes remission in adults with obesity and type 2 diabetes: a randomized controlled trial. [PDF]

BMC Med
Zhang S, Wang Y, Wang X, Leng M, Liu R, Li Z, Li J, Xiao J, Hou D, Gao X, Li C.   +10 more
europepmc   +1 more source

Novel Activity of Oral Hypoglycemic Agents Linked with Decreased Formation of Tryptophan Metabolite, Kynurenic Acid. [PDF]

Life (Basel)
Bednarz K, Kozieł K, Urbańska EM.
europepmc   +1 more source

Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis. [PDF]

Medicine (Baltimore), 2020
Liu ST, Su KQ, Zhang LH, Liu MH, Zhao WX.   +4 more
europepmc   +1 more source

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients. [PDF]

Saudi Pharm J, 2020
Alavudeen SS, Khobrani M, Dhanapal CK, Mir JI, Alshahrani SM, Khan NA, Alhossan A.   +6 more
europepmc   +1 more source